CA1224168A - Human growth hormone produced by recombinant dna in mouse cells - Google Patents

Human growth hormone produced by recombinant dna in mouse cells

Info

Publication number: CA1224168A
Authority: CA; Canada
Prior art keywords: cells; gene; plasmid; hgh; bpv
Prior art date: 1982-12-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000443993A

Other languages

English (en)

French (fr)

Inventor

Dean H. Hamer

George N. Pavlakis

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

US Department of Commerce

Original Assignee

US Department of Commerce

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-12-23

Filing date

1983-12-22

Publication date

1987-07-14

1983-12-22 Application filed by US Department of Commerce filed Critical US Department of Commerce

1987-07-14 Application granted granted Critical

1987-07-14 Publication of CA1224168A publication Critical patent/CA1224168A/en

Status Expired legal-status Critical Current

Links

108010000521 Human Growth Hormone Proteins 0.000 title claims abstract description 28
239000000854 Human Growth Hormone Substances 0.000 title claims abstract description 26
102000002265 Human Growth Hormone Human genes 0.000 title claims abstract description 23
108020004511 Recombinant DNA Proteins 0.000 title abstract description 10
108090000623 proteins and genes Proteins 0.000 claims abstract description 65
241000701822 Bovine papillomavirus Species 0.000 claims abstract description 42
238000000034 method Methods 0.000 claims abstract description 27
229910052793 cadmium Inorganic materials 0.000 claims abstract description 25
BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 claims abstract description 24
101000969137 Mus musculus Metallothionein-1 Proteins 0.000 claims abstract description 15
238000004519 manufacturing process Methods 0.000 claims abstract description 9
231100000816 toxic dose Toxicity 0.000 claims abstract description 7
239000003104 tissue culture media Substances 0.000 claims abstract description 5
239000013612 plasmid Substances 0.000 claims description 44
239000013598 vector Substances 0.000 claims description 38
241001131785 Escherichia coli HB101 Species 0.000 claims description 9
230000014509 gene expression Effects 0.000 claims description 6
101150026150 mt gene Proteins 0.000 claims description 6
230000029087 digestion Effects 0.000 claims description 5
241000283690 Bos taurus Species 0.000 claims description 4
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 4
229910052802 copper Inorganic materials 0.000 claims description 4
239000010949 copper Substances 0.000 claims description 4
229910052751 metal Inorganic materials 0.000 claims description 4
239000002184 metal Substances 0.000 claims description 4
230000003248 secreting effect Effects 0.000 claims description 4
102000012410 DNA Ligases Human genes 0.000 claims description 3
108010061982 DNA Ligases Proteins 0.000 claims description 3
238000010367 cloning Methods 0.000 claims description 3
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 3
229910052753 mercury Inorganic materials 0.000 claims description 3
208000003154 papilloma Diseases 0.000 claims description 3
230000028327 secretion Effects 0.000 claims description 2
230000001902 propagating effect Effects 0.000 claims 8
108020000946 Bacterial DNA Proteins 0.000 claims 2
231100000028 nontoxic concentration Toxicity 0.000 claims 2
241001631646 Papillomaviridae Species 0.000 claims 1
239000013600 plasmid vector Substances 0.000 claims 1
210000004027 cell Anatomy 0.000 abstract description 105
108090000157 Metallothionein Proteins 0.000 abstract description 28
102000003792 Metallothionein Human genes 0.000 abstract description 17
102000018997 Growth Hormone Human genes 0.000 abstract description 4
108010051696 Growth Hormone Proteins 0.000 abstract description 4
239000000122 growth hormone Substances 0.000 abstract description 4
210000004962 mammalian cell Anatomy 0.000 abstract description 4
238000000746 purification Methods 0.000 abstract description 4
239000003550 marker Substances 0.000 abstract description 3
108700039691 Genetic Promoter Regions Proteins 0.000 abstract 1
108020004414 DNA Proteins 0.000 description 26
YKYOUMDCQGMQQO-UHFFFAOYSA-L cadmium dichloride Chemical compound Cl[Cd]Cl YKYOUMDCQGMQQO-UHFFFAOYSA-L 0.000 description 26
239000012634 fragment Substances 0.000 description 17
DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 13
238000010276 construction Methods 0.000 description 12
241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 11
102000004169 proteins and genes Human genes 0.000 description 11
230000000644 propagated effect Effects 0.000 description 10
235000018102 proteins Nutrition 0.000 description 10
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 9
229960003957 dexamethasone Drugs 0.000 description 9
238000003127 radioimmunoassay Methods 0.000 description 9
UAHFGYDRQSXQEB-PWPYQVNISA-N 4-nle-α-msh Chemical group C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 UAHFGYDRQSXQEB-PWPYQVNISA-N 0.000 description 8
101710201354 Metallothionein A Proteins 0.000 description 8
101710094503 Metallothionein-1 Proteins 0.000 description 8
238000012546 transfer Methods 0.000 description 8
239000002609 medium Substances 0.000 description 7
239000000499 gel Substances 0.000 description 6
241000700605 Viruses Species 0.000 description 5
229910001385 heavy metal Inorganic materials 0.000 description 5
230000006698 induction Effects 0.000 description 5
108091008146 restriction endonucleases Proteins 0.000 description 5
241000282693 Cercopithecidae Species 0.000 description 4
108091092195 Intron Proteins 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
238000009630 liquid culture Methods 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
230000001131 transforming effect Effects 0.000 description 4
241000894006 Bacteria Species 0.000 description 3
241000588724 Escherichia coli Species 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
229940088597 hormone Drugs 0.000 description 3
239000005556 hormone Substances 0.000 description 3
238000009396 hybridization Methods 0.000 description 3
230000001817 pituitary effect Effects 0.000 description 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
239000000047 product Substances 0.000 description 3
108020005029 5' Flanking Region Proteins 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
102000055006 Calcitonin Human genes 0.000 description 2
108060001064 Calcitonin Proteins 0.000 description 2
102000053602 DNA Human genes 0.000 description 2
230000004543 DNA replication Effects 0.000 description 2
206010013883 Dwarfism Diseases 0.000 description 2
102000004877 Insulin Human genes 0.000 description 2
108090001061 Insulin Proteins 0.000 description 2
101150107952 MT-I gene Proteins 0.000 description 2
PYUSHNKNPOHWEZ-YFKPBYRVSA-N N-formyl-L-methionine Chemical group CSCC[C@@H](C(O)=O)NC=O PYUSHNKNPOHWEZ-YFKPBYRVSA-N 0.000 description 2
101710163270 Nuclease Proteins 0.000 description 2
108091000080 Phosphotransferase Proteins 0.000 description 2
108700005078 Synthetic Genes Proteins 0.000 description 2
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
230000004075 alteration Effects 0.000 description 2
150000001413 amino acids Chemical group 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
239000000427 antigen Substances 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 2
229960004015 calcitonin Drugs 0.000 description 2
229910000389 calcium phosphate Inorganic materials 0.000 description 2
239000001506 calcium phosphate Substances 0.000 description 2
235000011010 calcium phosphates Nutrition 0.000 description 2
239000013599 cloning vector Substances 0.000 description 2
238000000975 co-precipitation Methods 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000012894 fetal calf serum Substances 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
229940125396 insulin Drugs 0.000 description 2
238000002955 isolation Methods 0.000 description 2
210000003292 kidney cell Anatomy 0.000 description 2
150000002739 metals Chemical class 0.000 description 2
239000007758 minimum essential medium Substances 0.000 description 2
230000008707 rearrangement Effects 0.000 description 2
230000010076 replication Effects 0.000 description 2
239000000523 sample Substances 0.000 description 2
239000006152 selective media Substances 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
238000004114 suspension culture Methods 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
239000013603 viral vector Substances 0.000 description 2
229910052725 zinc Inorganic materials 0.000 description 2
239000011701 zinc Substances 0.000 description 2
108020005065 3' Flanking Region Proteins 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
101100396152 Arabidopsis thaliana IAA19 gene Proteins 0.000 description 1
241000972773 Aulopiformes Species 0.000 description 1
241000388186 Deltapapillomavirus 4 Species 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
206010062767 Hypophysitis Diseases 0.000 description 1
108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
206010027439 Metal poisoning Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
101100274486 Mus musculus Cited2 gene Proteins 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
108010087702 Penicillinase Proteins 0.000 description 1
101150096622 Smr2 gene Proteins 0.000 description 1
108091027544 Subgenomic mRNA Proteins 0.000 description 1
102000006601 Thymidine Kinase Human genes 0.000 description 1
108020004440 Thymidine kinase Proteins 0.000 description 1
108020005202 Viral DNA Proteins 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
238000003556 assay Methods 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
102000023732 binding proteins Human genes 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
230000000875 corresponding effect Effects 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
230000004927 fusion Effects 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
208000010501 heavy metal poisoning Diseases 0.000 description 1
208000002672 hepatitis B Diseases 0.000 description 1
230000013632 homeostatic process Effects 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
239000000411 inducer Substances 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
238000011031 large-scale manufacturing process Methods 0.000 description 1
238000005259 measurement Methods 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
238000004264 monolayer culture Methods 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
230000002023 papillomaviral effect Effects 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
210000003635 pituitary gland Anatomy 0.000 description 1
239000002574 poison Substances 0.000 description 1
231100000614 poison Toxicity 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
108010066381 preproinsulin Proteins 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
238000012545 processing Methods 0.000 description 1
229940070376 protein Drugs 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000004043 responsiveness Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
235000019515 salmon Nutrition 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000007787 solid Substances 0.000 description 1
241000894007 species Species 0.000 description 1
229940037128 systemic glucocorticoids Drugs 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
238000001890 transfection Methods 0.000 description 1
230000014616 translation Effects 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20041—Use of virus, viral particle or viral elements as a vector
- C12N2710/20043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Endocrinology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Physics & Mathematics (AREA)
Virology (AREA)
Toxicology (AREA)
Plant Pathology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

CA000443993A 1982-12-23 1983-12-22 Human growth hormone produced by recombinant dna in mouse cells Expired CA1224168A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US45278382A	1982-12-23	1982-12-23
US452,783		1982-12-23

Publications (1)

Publication Number	Publication Date
CA1224168A true CA1224168A (en)	1987-07-14

Family

ID=23797916

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000443993A Expired CA1224168A (en)	1982-12-23	1983-12-22	Human growth hormone produced by recombinant dna in mouse cells

Country Status (3)

Country	Link
JP (1)	JPS60500358A (ja)
CA (1)	CA1224168A (ja)
WO (1)	WO1984002534A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BG49718A3 (en) *	1983-07-15	1992-01-15	Bio Technology General Corp	Method for preparing of polypeptid with superoxiddismutasne activitty
ATE89314T1 (de) *	1985-02-13	1993-05-15	Scios Nova Inc	Menschlicher metallothionein ii-promotor in saeugetierexpressionssystemen.
FI861417A0 (fi) *	1985-04-15	1986-04-01	Endotronics Inc	Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
FR2596414B1 (fr) *	1986-03-28	1989-10-06	Pasteur Institut	Hybridomes obtenus a partir de lymphocytes d'animaux transgeniques portant un gene exprimant une proteine donnee et procede de preparation d'une telle proteine a partir de tels hybridomes
WO1988010300A1 (en) *	1987-06-22	1988-12-29	Medico Labs Ag	Heterologous viral peptide particle immunogens
WO2006108455A1 (en) *	2004-11-02	2006-10-19	Ares Trading S.A.	Serum-free cell culture medium for mammalian cells
US8273553B2 (en)	2004-11-02	2012-09-25	Ares Trading S.A.	Production of growth hormone in serum-free cell culture medium for mammalian cells

1983
- 1983-12-22 JP JP84500747A patent/JPS60500358A/ja active Pending
- 1983-12-22 WO PCT/US1983/002016 patent/WO1984002534A1/en unknown
- 1983-12-22 CA CA000443993A patent/CA1224168A/en not_active Expired

Also Published As

Publication number	Publication date
JPS60500358A (ja)	1985-03-22
WO1984002534A1 (en)	1984-07-05

Legal Events

Date	Code	Title	Description
2004-07-14	MKEX	Expiry

Publication	Publication Date	Title
AU664976B2 (en)	1995-12-14	Homologous recombination in mammalian cells
Lusky et al.	1984	Characterization of the bovine papilloma virus plasmid maintenance sequences
US4663281A (en)	1987-05-05	Enhanced production of proteinaceous materials in eucaryotic cells
US5089397A (en)	1992-02-18	Superior mammalian expression system
US6528313B1 (en)	2003-03-04	Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made
CA2071543C (en)	2005-02-22	Recombinant dna method and vectors for use therein
US4601978A (en)	1986-07-22	Mammalian metallothionein promoter system
ES2090297T5 (es)	2005-03-01	Produccion de proteinas que utilizan recombinacion homologa.
JP2721139B2 (ja)	1998-03-04	動物のインターフェロン
CA2215618A1 (en)	1996-09-26	Protein production and delivery
PH27198A (en)	1993-04-16	Expression and secretion of heterologous proteins by yarrowia lipolytica transformants
CA1224168A (en)	1987-07-14	Human growth hormone produced by recombinant dna in mouse cells
Meneguzzi et al.	1984	Plasmidial maintenance in rodent fibroblasts of a BPV1‐pBR322 shuttle vector without immediately apparent oncogenic transformation of the recipient cells.
EP0672156B1 (en)	2002-02-06	Bovine heat shock promoter and uses thereof
KR100259933B1 (ko)	2000-06-15	게놈 엘리먼트를 이용한 유전자 조작 및 발현방법
Stephens et al.	1987	The bovine papillomavirus genome and its uses as a eukaryotic vector.
JP2693361B2 (ja)	1997-12-24	組織プラスミノーゲン活性化因子の生産方法
US5747308A (en)	1998-05-05	Recombinant DNA method
JPS633793A (ja)	1988-01-08	Ｉｘ因子の発現を確実にする真核細胞内組込みベクタ−、得られた細胞系、およびこれらの製造方法
EP0225177B1 (en)	1993-09-01	Dna sequence coding for human tissue plasminogen activator
DK174993B1 (da)	2004-04-13	Fremgangsmåde til fremstilling af humant antithrombin III (ATIII) samt dertil egnede vektorer og værtsceller
JP2826114B2 (ja)	1998-11-18	遺伝子産物の製法
KR19990072793A (ko)	1999-09-27	Ｄｎａ서열의유전자수송을위한아데노바이러스전달벡터
WO1988005466A2 (en)	1988-07-28	Tandem gene eukaryotic expression vectors
CA2022356A1 (en)	1992-02-01	Method and materials for producing proteins